Peach IntelliHealth Inc is a New York based Artificial Intelligence & Machine Learning (AI/ML) healthcare company. Our mission is to improve patient outcomes and reduce healthcare costs through actionable data analytics.
Five MIT scientists, including three professors and two PhD graduates, specializing in AI/ML and healthcare launched Peach IntelliHealth. Klaudyne Hong, CEO and Co-Founder, received her PhD from MIT and subsequently led R&D at Johnson and Johnson and ScheringAG for over a dozen years, tackling Cancer, Stroke, Parkinson’s, and Cardiovascular diseases. She later founded a bioscience partnering firm to help other biomedical companies succeed. She is passionate about disruptive innovations and co-founded Peach to create novel transformative solutions across diseases. Her Co-Founder, Bruce Tidor, is MIT Professor of Computer Science and Biological Engineering. He trained at Harvard, attended Oxford as a Marshall Scholar, co-directed MIT’s Computational and Systems Biology Initiative, and is instrumental for Peach technology development. The extended Peach team includes full-time scientists and engineers in the US and Singapore.
Prevention is Better than Cure. Our lead product, Peach ACE, uses proprietary AI/ML to predict patient trajectory several hours BEFORE measurable signals. Using Peach ACE, healthcare providers can gain advanced insights into patient response and leverage an extended intervention window to enhance patient outcomes.
Investors + Partners
We support synergistic partnerships that can accelerate delivery of solutions to patients. If you are a researcher or an entity that shares our passion, you are invited to contact us for collaborative opportunities at email@example.com.
124 West 60th Street
New York, NY 10023